Want to see AMS full AI Analyst Report?
AMS Stock Chart & Stats
$1.46
$0.01(0.68%)
At close: 4:00 PM EDT
$1.46
$0.01(0.68%)
Day’s Range― - ―
52-Week Range$1.25 - $3.11
Previous CloseN/A
Volume3.28K
Average Volume (3M)78.93K
Market Cap
$9.94M
Enterprise Value$28.90
Total Cash (Recent Filing)$5.22M
Total Debt (Recent Filing)$21.19M
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Aug 19, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding6,625,000
10 Day Avg. Volume41,017
30 Day Avg. Volume78,931
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.58
Price to Sales (P/S)0.50
P/FCF Ratio-3.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.05
Revenue Forecast (FY)$29.73M
Bulls Say, Bears Say
Bulls Say
Improved LeverageMaterial reduction in leverage (debt-to-equity ~0.18) strengthens balance sheet resilience, lowering default risk and interest burden. This durable capital structure gives management more flexibility to fund ramps, pursue negotiated asset sales, or absorb project delays without immediate solvency pressure.
Operational MomentumSustained organic growth across services (top-line +15.9%, Direct Patient Care +30.2%) and adjusted EBITDA expansion signal improving utilization and unit economics. If utilization trends persist, revenue mix and operating leverage could drive continued margin recovery and greater cash generation over the medium term.
Specialized Therapy Volume Growth & PipelineGrowth in proton and Gamma Knife volumes demonstrates demand for AMS's specialized offerings and supports longer-term site economics. A multi-site pipeline (Guadalajara start, Rhode Island approvals) creates a multi-year revenue runway tied to durable clinical demand rather than cyclical services.
Bears Say
GAAP UnprofitabilityPersisting GAAP losses reduce retained earnings and limit ability to self-fund expansion or absorb setbacks without external capital. Ongoing unprofitability also constrains strategic optionality, increases reliance on lender goodwill, and makes multi-year projects dependent on consistent margin improvement.
Negative And Volatile Free Cash FlowIntermittent FCF and recent negative free cash flow reduce internal funding for maintenance capex and site ramps, raising execution risk for new centers. Volatility in cash generation forces recurring financing needs, which can be costly or restrictive and impair long-term reinvestment plans.
Financing & Covenant StressActive defaults, a standstill amendment, and related-party subordinated financing constrain liquidity and strategic flexibility. Covenant relief and encumbered assets raise refinancing and dilution risk, making long-term project execution and investment pacing contingent on successful renegotiation or asset sales.
American Shared Hospital Services News
AMS FAQ
What was American Shared Hospital Services’s price range in the past 12 months?
American Shared Hospital Services lowest stock price was $1.25 and its highest was $3.11 in the past 12 months.
What is American Shared Hospital Services’s market cap?
American Shared Hospital Services’s market cap is $9.94M.
When is American Shared Hospital Services’s upcoming earnings report date?
American Shared Hospital Services’s upcoming earnings report date is Aug 19, 2026 which is in 16 days.
How were American Shared Hospital Services’s earnings last quarter?
Currently, no data Available
Is American Shared Hospital Services overvalued?
According to Wall Street analysts American Shared Hospital Services’s price is currently Overvalued.
Does American Shared Hospital Services pay dividends?
American Shared Hospital Services does not currently pay dividends.
What is American Shared Hospital Services’s EPS estimate?
American Shared Hospital Services’s EPS estimate is -0.02.
How many shares outstanding does American Shared Hospital Services have?
American Shared Hospital Services has 6,625,000 shares outstanding.
What happened to American Shared Hospital Services’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of American Shared Hospital Services?
Currently, no hedge funds are holding shares in AMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
American Shared Hospital Services
American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat conditions such as malignant and benign brain tumors, arteriovenous malformations, and trigeminal neuralgia. They also facilitate financing for Leksell Gamma Knife units. Additionally, the firm operates proton beam radiation therapy centers in Orlando, Florida, and Long Beach, California. Customers further benefit from comprehensive support encompassing planning, installation, reimbursement guidance, and marketing strategies. As of December 31, 2021, their portfolio included 115 active Gamma Knife units across the United States, complemented by two units in South America (Lima, Peru, and Guayaquil, Ecuador), and one proton beam radiation therapy system. Established in 1980, American Shared Hospital Services maintains its headquarters in San Francisco, California.
AMS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented meaningful operational and financial improvements: double-digit top-line growth (+15.9%), strong expansion in the direct patient services segment (+30.2%), adjusted EBITDA growth (+18.4%), improved gross margins (+44% in dollars) and a stronger cash position. These positives are tempered by an ongoing GAAP net loss ($0.6M), higher operating and maintenance costs associated with ramping centers, and continuing lender discussions and multi-year timelines for major projects. On balance, the company demonstrated clear operational momentum and improving financial metrics, while still managing near-term cost and financing execution risks.View all AMS earnings summariesTechnical Analysis
Ownership Overview
34.42% Insiders
6.59% Mutual Funds
0.45% Other Institutional Investors
57.31% Public Companies and
Individual Investors